Literature DB >> 32068912

Successful use of guselkumab in the treatment of severe hidradenitis suppurativa.

N Kearney1, N Byrne1, B Kirby1,2, R Hughes1,2.   

Abstract

Entities:  

Year:  2020        PMID： 32068912     DOI： 10.1111/ced.14199

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN： 0307-6938            Impact factor:   3.470


× No keyword cloud information.
  5 in total

Review 1.  Hidradenitis Suppurativa: Host-Microbe and Immune Pathogenesis Underlie Important Future Directions.

Authors:  Simon W Jiang; Melodi Javid Whitley; Paula Mariottoni; Tarannum Jaleel; Amanda S MacLeod
Journal:  JID Innov       Date:  2021-01-12

Review 2.  New and Emerging Targeted Therapies for Hidradenitis Suppurativa.

Authors:  Adela Markota Čagalj; Branka Marinović; Zrinka Bukvić Mokos
Journal:  Int J Mol Sci       Date:  2022-03-29       Impact factor: 5.923

Review 3.  Innate immunity and microbial dysbiosis in hidradenitis suppurativa - vicious cycle of chronic inflammation.

Authors:  Divya Chopra; Rachel A Arens; Watcharee Amornpairoj; Michelle A Lowes; Marjana Tomic-Canic; Natasa Strbo; Hadar Lev-Tov; Irena Pastar
Journal:  Front Immunol       Date:  2022-07-28       Impact factor: 8.786

Review 4.  Immunomodulatory Drugs in the Treatment of Hidradenitis Suppurativa-Possibilities and Limitations.

Authors:  Zuzanna Świerczewska; Miłosz Lewandowski; Agnieszka Surowiecka; Wioletta Barańska-Rybak
Journal:  Int J Mol Sci       Date:  2022-08-26       Impact factor: 6.208

5.  The inflammatory proteome of hidradenitis suppurativa skin is more expansive than that of psoriasis vulgaris.

Authors:  Kristina Navrazhina; Sandra Garcet; John W Frew; Xiuzhong Zheng; Israel Coats; Emma Guttman-Yassky; James G Krueger
Journal:  J Am Acad Dermatol       Date:  2021-07-30       Impact factor: 11.527
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.